van der Toorn, Janine E.
Vernooij, Meike W.
Ikram, M. Arfan
Kavousi, Maryam
Bos, Daniel
Funding for this research was provided by:
Erasmus Medisch Centrum
Erasmus Universiteit Rotterdam
ZonMw (91616079)
the Netherlands Organization for Health Research and Development
the Research Institute for Diseases in the Elderly
the Netherlands Genomics Initiative
Ministerie van Onderwijs, Cultuur en Wetenschap
Ministerie van Volksgezondheid, Welzijn en Sport
BrightFocus Foundation (A2017424F)
Alzheimer's Association (AARG-21-846504)
Article History
Received: 29 June 2023
Revised: 16 November 2023
Accepted: 9 December 2023
First Online: 15 January 2024
Declarations
:
: The scientific guarantor of this publication is Daniel Bos.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: No complex statistical methods were necessary.
: Written informed consent was obtained from all subjects in this study.
: Institutional Review Board approval was obtained from Medical Ethics Committee of the Erasmus MC (registration number MEC 02.1015) and the Dutch Ministry of Health, Welfare and Sport (Population Screening Act WBO, license number 1071272–159521-PG).
: The current study includes a population who underwent CT examinations within the Rotterdam Study. Based on the cohort, several studies have been published covering different research questions.
: • prospective• observational• multicentre study